Its role Owner
PiSA Farmacéutica, also known as Grupo PiSA, is a privately held, 100% Mexican pharmaceutical company headquartered in Guadalajara, Jalisco. Founded in 1945 by Professor Miguel Álvarez Ochoa as Productos Infantiles S.A., it initially focused on pediatric medications and has grown into one of Mexico's leading pharmaceutical manufacturers with over 80 years of operation.
The company specializes in the development, manufacturing, commercialization, and distribution of medicines and medical devices across 17 therapeutic lines, including pediatrics, nephrology, infectology, anesthesiology, oncology, immunosuppressants, parenteral nutrition, dialysis solutions, and biotechnology products. It produces more than 1,500 brands and operates 14 to 16 production plants strategically located throughout Mexico, with key facilities in Guadalajara (injectables, cephalosporins, penicillins, biopharmaceuticals), Coyoacán in Mexico City (oncology and powders), and Tlajomulco (oncology, immunosuppressants, dialysis, and Electrolit®). It also maintains distribution centers and international operations.
PiSA exports to the United States, Latin America, and the Caribbean, serving both public and private healthcare sectors. The group structure includes subsidiaries such as PiSA Biotec and various plant-specific operations. With approximately 20,000 to 30,000 employees, it ranks among the top 10 pharmaceutical companies in Mexico by market share (around 3% nationally) and is recognized for innovation, quality certifications (including GMP, ISO, and ESR), and contract manufacturing services. It emphasizes social responsibility and technological advancement in its facilities.
Also known as Productos Infantiles S.A., Laboratorios PiSA, Grupo PiSA, PISA® Farmacéutica, and PiSA Biotec.
chemXplore tracks 1 project involving PiSA.
active all projects
